drugset / Trial / NCT00771914
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Phase 1/2
Completed
27 enrolled
University of Rochester
American College of Clinical Pharmacy · collabCornell University · collabGlaxoSmithKline · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine if omega-3 fatty acids enhance the antiplatelet effects of aspirin.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-01
- Completion
- 2009-01
Outcome
Met primary endpoint
registry Placebo vs Both Aspirin and Lovaza; p = 0.03; Mean Difference (Final Values) 30; Wilcoxon (Mann-Whitney) NCT00771914 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Lovaza | Other / unclassified | 4 g | — |
Indications
No indication recorded.